Small Study Shows Benefits of Treadmill Training in Cooled Room in People with MS-Related Walking Impairment
February 3, 2020
Harness-supported, vigorous treadmill training in a cooled room improved walking, fatigue, fitness and quality-of-life in a small University of Newfoundland study involving eight people with MS who used assistive devices for walking. Larger studies are necessary to confirm the safety and effectiveness of this strategy for improving symptoms in people with mobility impairments.
"Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study"
- The benefits of this training were maintained after three months in 7 of the participants. Those whose fitness improved after training showed increases in a protein involved in nerve protection (brain-derived neurotrophic factor) and decreases in an immune messenger protein linked to inflammation (interleukin-6).
- Training sessions lasted up to 40 minutes, and occurred three times a week for 10 weeks in a room that was cooled to 16°C (61°F) to counteract symptoms that can arise with increased body heat. Intensity and speed were gradually increased, as tolerated. Manual support was provided to individuals with severe walking impairments as required. Learn more about strategies to improve a workout with MS.
- A larger study in 70 people with MS is planned, with funding from the MS Society of Canada. This study will compare vigorous versus low intensity treadmill training in a cooled room, and is measuring effects primarily on walking speed, but also on other factors, such as depression, cognition, and imaging measures of brain repair.
is published by Drs. Augustine Devasahayam, Michelle Ploughman, and colleagues in BMC Neurology
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.